510(k) K962099
K962099 is an FDA 510(k) premarket notification submitted by Boehringer Mannheim Corp. for the device "CEDIA PROCAINAMIDE ASSAY". The FDA issued a decision of Substantially Equivalent on August 27, 1996. The device falls under product code LAR (Enzyme Immunoassay, Procainamide), a Class II device regulated under 21 CFR 862.3320. Boehringer Mannheim Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 27, 1996
- Date Received
- May 29, 1996
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Procainamide
- Device Class
- Class II
- Regulation Number
- 862.3320
- Review Panel
- TX
- Submission Type